Occasionally, researchers will need to submit their research to more than one research committee. This guidance addresses when submitting to the IBC and IRB is required. The Principal Investigator ...

Presented by Mississippi State Office of Research Compliance and Security staff, this training is appropriate for all faculty, staff and students involved in research activities. If you are a student, ...

The purpose of the IRB Liaison Working Group is to establish a structured, bi-directional feedback system between the Office of the Institutional Review Board (OIRB) and the schools and colleges ...

The IRB reviews research involving human subjects if one or more of the following apply: The research is sponsored by WMU, regardless of the location of the project. The research is conducted by, or ...

The Human Ethics module of ROAMWyo will streamline all aspects of human subjects research: protocol submission, review, and approval, as well as provide a dashboard where researchers can view the ...

As of Sept. 12, 2023, Case Western Reserve University and the Cleveland Clinic Foundation have entered into a Mutual Non-Disclosure Agreement (Protocol Sharing with Marking Requirement). This ...

Any research that involves human subjects, whether funded or not, that is undertaken by a WIU faculty, academic staff or student or supported by Western Illinois University, must be reviewed by the ...

As the curtain closed on 2024, FDA issued a new draft guidance to assist clinical trial sponsors, investigators, and institutional review boards (“IRBs”) with defining, identifying, and reporting ...

Access to IRB (formerly referred to as PHSC) protocols in the legacy system, compliance.wm.edu, is limited to view access. Any new Human Subjects protocols must be initiated in SPARCS. The data ...

The Institute for Healthcare Informatics (IHI) actively supports clinical trials and streamlines the research process through various initiatives: Speed-to-value: We focus on enhancing recruitment and ...

MELBOURNE, Australia and NEW YORK, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (‘Incannex’ or the ‘Company’), a pharmaceutical company developing unique medicinal ...